Anti-cancer drug discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds
Open accessAbstract
Throughout medical history, plant products have been shown to be valuable sources of novel anti-cancer drugs. Examples are the Vinca alkaloids, the taxanes, and the camptothecins, derived from the Madagscan periwinkle plant Catharantus roseus, the Pacific yew Taxus brevifolia, and the Chinese tree Camptotheca acuminata, respectively. For this reason, the South-American Office for Anti-Cancer Drug Development has implemented a large-scale project of acquisition and testing of compounds isolated from South American medicinal plants. The species are selected on the basis of a potentially useful phytochemical composition by consulting ethnopharmacological, chemosystemic, and ecological information. The collected samples are dried and first extracted with an organic solvent, then with distilled water. These crude extracts are evaluated at a concentration of 50 μg/ml for antiproliferative activity against one cell line. Extracts that significantly inhibit the growth of the cells (≥50%) at relatively low concentrations (≤50 μg/ml) are submitted to the more comprehensive disease-oriented screen of the U.S. National Cancer Institute. In parallel, these samples are further purified by bioassay-guided purification, involving repeated fractionation by diverse chromatography methods. If the active substance is expected to represent a novel structure, it is identified by appropriate chemical techniques, mechanistic studies are performed with a wide diversity of tumor models and laboratory techniques, and efforts are undertaken for the synthesis of potentially more useful analogs.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Wani, M. C., Taylor, H. L., Wall, M. E., COGGON, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,083 · see citing works
Monks, A. P., Scudiero, D. A., Skehan, P., Shoemaker, R. H., Paull, K. D., Vistica, D. T., Hose, C. D., Langley, J. W., Cronise, P., Vaigro-Wolff, A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.757 · Cited by 3,305 · see citing works
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke‐Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,798 · see citing works
Wall, M. E., Wani, M. C., Cook, C. E., Palmer, K. H., McPhail, A., & Sim, G. A. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00968a057 · Cited by 2,262 · see citing works
Natural Products in Drug Discovery and Development
Cragg, G. M. L., Newman, D. J., & Snader, K. M. (1997) · Journal of Natural Products · doi:10.1021/np9604893 · Cited by 1,589 · see citing works
Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease
DeVita, V. T., SERPICK, A. A., & CARBONE, P. P. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-6-881 · Cited by 1,445 · see citing works
Williams, S. D., Birch, R., Einhorn, L. H., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162302 · Cited by 1,181 · see citing works
Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A. P., Scudiero, D. A., Rubinstein, L., Plowman, J., & Boyd, M. R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1088 · Cited by 970 · see citing works
The Alkaloids, Chemistry and Pharmacology
(1992) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(92)90195-7 · Cited by 913 · see citing works
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
Pettit, G. R., Singh, S. B., Hamel, E., et al. (1989) · Cellular and Molecular Life Sciences · doi:10.1007/bf01954881 · Cited by 794 · see citing works
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_4 · Cited by 787 · see citing works
Cancer principles and practice of oncology
Kerin, M. J. (1997) · Surgical Oncology · doi:10.1016/s0960-7404(97)90012-8 · Cited by 744 · see citing works
CRC Handbook of Ayurvedic Medicinal Plants
Kapoor, L. D. (2018) · CRC Press eBooks · doi:10.1201/9781351070997 · Cited by 732 · see citing works
Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
Ringel, I., & Horwitz, S. B. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.4.288 · Cited by 678 · see citing works
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.
Dark, G. G., Hill, S. A., Prise, V. E., Tozer, G. M., Pettit, G. R., & Chaplin, D. J. (1997) · PubMed · Cited by 623 · see citing works
The Current Status of Heterocyclic Combinatorial Libraries
Nefzi, A., Ostresh, J. M., & Houghten, R. A. (1997) · Chemical Reviews · doi:10.1021/cr960010b · Cited by 586 · see citing works
THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.
JOHNSON, I. S., Jg, A., Gorman, M., & Jp, B. (1963) · PubMed · Cited by 564 · see citing works
Plants used against cancer. A survey.
Hartwell, J. L. (1969) · PubMed · Cited by 508 · see citing works
Anticancer agents based on natural product models
Cassady, J. M., & Douros, J. (1980) · Academic Press eBooks · Cited by 412 · see citing works
Senderowicz, A. M., Headlee, D. J., Stinson, S. F., Lush, R. M., Kalil, N., Villalba, L., Hill, K. D., Steinberg, S. M., Figg, W. D., Tompkins, A. C., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2986 · Cited by 404 · see citing works
Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6
Pettit, G. R., Singh, S. B., Boyd, M. R., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00010a011 · Cited by 397 · see citing works
Creemers, G. J., Bolis, G., Gore, M. E., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.12.3056 · Cited by 386 · see citing works
Forero, E., & Hartwell, J. L. (1989) · The Bryologist · doi:10.2307/3244038 · Cited by 376 · see citing works
Handbook of Ayurvedic Medicinal Plants
Kapoor, L. D. (2017) · Routledge eBooks · doi:10.1201/9780203719473 · Cited by 372 · see citing works
Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275
Kaur, G., Stetler-Stevenson, M. A., Sebers, S., et al. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.22.1736 · Cited by 353 · see citing works
Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275
Losiewicz, M. D., Carlson, B. A., Kaur, G., Sausville, E. A., & Worland, P. J. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1742 · Cited by 346 · see citing works
Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy
Sedlacek, H., Czech, J., Naik, R., Kaur, G., Worland, P., Losiewicz, M., Parker, B., Carlson, B., Smith, A., Senderowicz, A., et al. (1996) · International Journal of Oncology · doi:10.3892/ijo.9.6.1143 · Cited by 275 · see citing works
Comprehensive Survey of Combinatorial Library Synthesis: 1998
Dolle, R. E., & Nelson, K. H. (1999) · Journal of Combinatorial Chemistry · doi:10.1021/cc9900192 · Cited by 270 · see citing works
Dittrich, H., & Kutchan, T. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9969 · Cited by 268 · see citing works
Comprehensive Survey of Combinatorial Library Synthesis: 2000
Dolle, R. E. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc010049g · Cited by 257 · see citing works
Medicinal plants in Europe containing pyrrolizidine alkaloids.
Roeder, E. (1995) · PubMed · Cited by 257 · see citing works
Plantas da medicina popular no Rio Grande do Sul
Simões, C. M. O. (1998) · Cited by 234 · see citing works
TAKAHASHI, I., Nakanishi, S., Kobayashi, E., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92730-7 · Cited by 223 · see citing works
The Role of Ethnopharmacology in Drug Development
Farnsworth, N. R. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514009.ch2 · Cited by 208 · see citing works
Antibacterial phloroglucinols and flavonoids from Hypericum brasiliense
Rocha, L., Marston, A., Potterat, O., et al. (1995) · Phytochemistry · doi:10.1016/0031-9422(95)00507-4 · Cited by 197 · see citing works
Medicines from nature: are natural products still relevant to drug discovery?
Harvey, A. R. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01346-2 · Cited by 186 · see citing works
Stähblin, H. (1973) · European Journal of Cancer (1965) · doi:10.1016/s0014-2964(73)80021-0 · Cited by 183 · see citing works
Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]
Kantarjian, H. M., O'Brien, S. M., Anderlini, P. N., & Talpaz, M. (1996) · Blood · doi:10.1182/blood.v87.8.3069.bloodjournal8783069 · Cited by 177 · see citing works
Structures of harringtonine, isoharringtonine, and homoharringtonine
Powell, R. G., Weisleder, D., Smith, C. R., et al. (1970) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)97839-6 · Cited by 175 · see citing works
Samuelsson, G. (1992) · Cited by 155 · see citing works
Worland, P. J., Kaur, G., Stetler‐Stevenson, M., et al. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90590-s · Cited by 145 · see citing works
Paoletti, C., Pecq, J. B. L., Xuong, N. D., Juret, P., Garnier, H., Amiel, J.-L., & Rouëssé, J. (1980) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-81488-4_15 · Cited by 144 · see citing works
Induction of apoptosis by beta-lapachone in human prostate cancer cells.
Li, C. J., Wang, C., & Pardee, A. B. (1995) · PubMed · Cited by 144 · see citing works
Antimicrotubule properties of benzophenanthridine alkaloids
Wolff, J., & Knipling, L. (1993) · Biochemistry · doi:10.1021/bi00211a047 · Cited by 140 · see citing works
(1997) · PubMed · Cited by 134 · see citing works
Zhang, D., Botos, I., Gomis‐Rüth, F. X., Doll, R. J., Blood, C. H., Njoroge, F. G., Fox, J. W., Bode, W., & MEYER, E. F. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8447 · Cited by 134 · see citing works
The Ethnobotanical Approach to Drug Discovery: Strengths and Limitations
Cox, P. A. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514634.ch3 · Cited by 132 · see citing works
Inhibition of topoisomerase I function by nitidine and fagaronine
Wang, L., Johnson, R. K., & Hecht, S. M. (1993) · Chemical Research in Toxicology · doi:10.1021/tx00036a010 · Cited by 130 · see citing works
Natural Products and Drug Development
Phillipson, J. D. (1985) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(85)90081-1 · Cited by 122 · see citing works
Natural products and drug development
Cordell, G. A. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90052-7 · Cited by 113 · see citing works
The structure of rohitukine, the main alkaloid of (Syn. ) (meliaceae)
Harmon, A. D., Weiß, U., & Silverton, J. V. (1979) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)93556-7 · Cited by 107 · see citing works
Development of human tumor cell line panels for use in disease-oriented drug screening.
Shoemaker, R. H., Monks, A. P., Alley, M. C., Scudiero, D. A., Fine, D. L., McLemore, T. L., Abbott, B. J., Paull, K. D., Mayo, J. G., & Boyd, M. R. (1988) · PubMed · Cited by 106 · see citing works
Essential drugs for cancer therapy: A World Health Organization consultation
Sikora, K., Advani, S., Koroltchouk, V., Magrath, I. T., Lévy, L., Pinedo, H. M., Schwartsmann, G., Tattersall, M., & Yan, S. (1999) · Annals of Oncology · doi:10.1023/a:1008367822016 · Cited by 106 · see citing works
Self-citationRecognition and Evaluation of Lapachol as an Antitumor Agent
RAO, K. V., Mcbride, T. J., & Oleson, J. J. (1968) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 104 · see citing works
Cytotoxic Aromatic Triterpenes from Maytenus ilicifolia and Maytenus chuchuhuasca
Shirota, O., Morita, H., Takeya, K., Itokawa, H., & Iitaka, Y. (1994) · Journal of Natural Products · doi:10.1021/np50114a009 · Cited by 102 · see citing works
Wu, T.-S., Lin, Y., Haruna, M., et al. (1991) · Journal of Natural Products · doi:10.1021/np50075a011 · Cited by 100 · see citing works
Ethnobotany and the Identification of Therapeutic Agents from the Rainforest
Balick, M. J. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514009.ch3 · Cited by 99 · see citing works
Immunomodulatory and Anti-Tumour Polysaccharides from Medicinal Plants
Wong, C. K., Leung, K. N., Fung, K., et al. (1994) · Journal of International Medical Research · doi:10.1177/030006059402200601 · Cited by 99 · see citing works
Types of anticancer agents isolated from plants.
Hartwell, J. L. (1976) · PubMed · Cited by 98 · see citing works
Antitumor agent, physalin F from Physalis angulata L.
Chiang, H. C., Jaw, S. M., Chen, C.-F., et al. (1992) · PubMed · Cited by 94 · see citing works
Decreased mortality of Norman murine sarcoma in mice treated with the immunomodulator, Acemannan.
Peng, S. Y., Norman, J. E., Curtin, G., et al. (1991) · PubMed · Cited by 94 · see citing works
Clinical trials referral resource.
Cheson, B. D., Abrams, J., McCabe, M. S., et al. (1990) · PubMed · Cited by 94 · see citing works
Couldwell, W. T., Gopalakrishna, R., Hinton, D. R., et al. (1994) · Neurosurgery · doi:10.1227/00006123-199410000-00017 · Cited by 93 · see citing works
Dolle, R. E. (1997) · Molecular Diversity · doi:10.1023/a:1009699413828 · Cited by 92 · see citing works
Inhibitory effects of physalin B and physalin F on various human leukemia cells in vitro.
Hc, C., Jaw, S. M., & Pm, C. (1992) · PubMed · Cited by 90 · see citing works
Nefzi, A., Dooley, C. T., Ostresh, J. M., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00412-0 · Cited by 84 · see citing works
Morita, H., NAKAYAMA, M., Kojima, H., et al. (1991) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.39.693 · Cited by 83 · see citing works
What can toxins tell us for drug discovery?
Harvey, A. L., Bradley, K. N., Cochran, S., et al. (1998) · Toxicon · doi:10.1016/s0041-0101(98)00156-1 · Cited by 83 · see citing works
New antitumor principles, casearins A-F, for Casearia sylvestris Sw. (Flacourtiaceae).
Itokawa, H., Totsuka, N., Morita, H., et al. (1990) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.38.3384 · Cited by 78 · see citing works
In VitroCytotoxicity of a Series of Quassinoids fromBrucea javanicaFruits Against KB Cells
Anderson, M. M., O’Neill, M. J., Phillipson, J. D., et al. (1991) · Planta Medica · doi:10.1055/s-2006-960020 · Cited by 77 · see citing works
Ciba Foundation Symposium 185 ‐ Ethnobotany and the Search for New Drugs
(2007) · Novartis Foundation symposium · doi:10.1002/9780470514634 · Cited by 75 · see citing works
Cytotoxic Constituents of Baccharis gaudichaudiana
Fullas, F., Hussain, R. A., Chai, H.-B., Pezzuto, J. M., Soejarto, D. D., & Kinghorn, A. D. (1994) · Journal of Natural Products · doi:10.1021/np50108a017 · Cited by 71 · see citing works
Selectively Cytotoxic Diterpenes from Euphorbia poisonii
Fatope, M. O., Zeng, L., Ohayaga, J. E., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950509i · Cited by 70 · see citing works
Kuo, Y., King, M.-L., Chen, C.-F., et al. (1994) · Journal of Natural Products · doi:10.1021/np50104a011 · Cited by 70 · see citing works
el-Zayat, A. A. E., Degen, D. R., Drabek, S. M., et al. (1993) · Anti-Cancer Drugs · doi:10.1097/00001813-199302000-00002 · Cited by 70 · see citing works
Acquired Dementia with Retinitis Pigmentosa
Grollman, E. M., & Papacostas, S. (1994) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879400700104 · Cited by 62 · see citing works
The pharmacology of extinction
Huxtable, R. J. (1992) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(92)90002-9 · Cited by 62 · see citing works
Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor
Dorr, R. T., Dvorakova, K., Snead, K., et al. (1996) · Investigational New Drugs · doi:10.1007/bf00210783 · Cited by 62 · see citing works
Robins, D. J. (1995) · Natural Product Reports · doi:10.1039/np9951200413 · Cited by 62 · see citing works
Amazonian Ethnobotany and the Search for New Drugs
Schultes, R. E. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514634.ch8 · Cited by 55 · see citing works
Metabolism of plant-derived anticancer agents
Cragg, G. M. L., & Suffness, M. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90006-x · Cited by 55 · see citing works
Antoun, M. D., Abramson, D., Tyson, R. L., et al. (1981) · Journal of Natural Products · doi:10.1021/np50017a013 · Cited by 54 · see citing works
Directed combinatorial chemistry.
Hogan, J. C. (1996) · PubMed · Cited by 52 · see citing works
Discovery of enzyme inhibitors through combinatorial chemistry
Dolle, R. E. (1997) · Molecular Diversity · doi:10.1007/bf01715638 · Cited by 51 · see citing works
Clinical highlights from the National Cancer Data Base: 1996
Jessup, J. M., McGinnis, L. S., Winchester, D. P., et al. (1996) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.46.3.185 · Cited by 46 · see citing works
Rowinsky, E. K. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)90879-6 · Cited by 46 · see citing works
Panizza, S. (2000) · Cited by 43 · see citing works
Oncogene signal transduction inhibitors from medicinal plants.
Chang, C. J., Ashendel, C. L., Geahlen, R. L., et al. (1997) · PubMed · Cited by 42 · see citing works
Early clinical studies with lapachol (NSC-11905).
Block, J. B., Serpick, A. A., Miller, W., et al. (1974) · PubMed · Cited by 40 · see citing works
In vitro antioxidant and cytotoxic activity of extracts of Baccharis coridifolia DC
Mongelli, E., Desmarchelier, C., Talou, J. R., et al. (1997) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(97)00106-2 · Cited by 40 · see citing works
Kupchan, S. M., & Smith, R. M. (1977) · The Journal of Organic Chemistry · doi:10.1021/jo00421a023 · Cited by 33 · see citing works
Summary of the Workshop on Drug Development, Biological Diversity, and Economic Growth
Schweitzer, J., Handley, F. G., Edwards, J. D., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.18.1294 · Cited by 32 · see citing works
Identification of Natural Antimutagens with Modulating Effects on DNA Repair
Vuković‐Gačić, B., & Simić, D. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2984-2_25 · Cited by 32 · see citing works
Development of a genetically engineered vaccine against feline leukemia virus infection
Kensil, C. R., Barrett, C., Kushner, N. N., et al. (1991) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1991.199.10.1423 · Cited by 31 · see citing works
Effect of antioxidants on radical intensity and cytotoxic activity of eugenol.
Satoh, K., Ida, Y., Sakagami, H., et al. (1998) · PubMed · Cited by 30 · see citing works
Mode of action of the antitumor compound girodazole (RP 49532A, NSC 627434)
Colson, G., Rabault, B., Lavelle, F., et al. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90701-j · Cited by 30 · see citing works
Scientific Basis of Cancer Chemotherapy
(1969) · Springer eBooks · doi:10.1007/978-3-642-88147-3 · Cited by 28 · see citing works
Clinical trials referral resource. Clinical trials of flavopiridol.
Wright, J., Blatner, G. L., & Cheson, B. D. (1998) · PubMed · Cited by 28 · see citing works
Cerebral microvessels in Alzheimer's have reduced protein kinase C activity.
Grammas, P., Moore, P., Botchlet, T., Hanson-Painton, O., Cooper, D., Ball, M., & Roher, A. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00048-j · Cited by 26 · see citing works
Paulini, H., Popp, R., Schimmer, O., et al. (1991) · Planta Medica · doi:10.1055/s-2006-960019 · Cited by 21 · see citing works
Stirpe, F., Licastro, F., Morini, M. C., et al. (1993) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(93)90093-n · Cited by 21 · see citing works
Gebara, V. C., Petricevich, V. L., Raw, I., et al. (1995) · Biotechnology and Applied Biochemistry · doi:10.1111/j.1470-8744.1995.tb00341.x · Cited by 21 · see citing works
Schall, V. T., de Vasconcellos, M. C., Valent, G. U., et al. (1991) · PubMed · Cited by 19 · see citing works
Sommer, H., & Harrer, G. (1994) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879400701s04 · Cited by 19 · see citing works
Schimmer, O., Kiefer, J., & Paulini, H. (1991) · Mutagenesis · doi:10.1093/mutage/6.6.501 · Cited by 17 · see citing works
Zhang, W., Hinton, D. R., Surnock, A. A., et al. (1996) · Neurosurgery · doi:10.1097/00006123-199603000-00035 · Cited by 17 · see citing works
Ciba Foundation Symposium 154 ‐ Bioactive Compounds from Plants
(2007) · Novartis Foundation symposium · doi:10.1002/9780470514009 · Cited by 17 · see citing works
Schneede, P., Schlenker, B., & Hungerhuber, E. (2006) · Der Urologe · doi:10.1007/s00120-006-1232-2 · Cited by 16 · see citing works
Rehm, S., & Devor, D. E. (1993) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01200723 · Cited by 15 · see citing works
Cell-Based Screen for Identification of Inhibitors of Tubulin Polymerization
Kokoshka, J. M., Ireland, C. M., & Barrows, L. R. (1996) · Journal of Natural Products · doi:10.1021/np960144k · Cited by 15 · see citing works
Anticancer Drugs: Antimetabolite Metabolism and Natural Anticancer Agents
Powis, G. (1994) · Medical Entomology and Zoology · Cited by 14 · see citing works
Irinotecan for colorectal cancer
Pozzo, C., Cassano, A., & Barone, C. (1998) · PharmacoEconomics & Outcomes News · doi:10.1007/bf03273532 · Cited by 14 · see citing works
Phase II Trial of Indicine N-Oxide in Relapsed Acute Leukemia of Childhood
Miser, J. S., Smithson, W. A., Krivit, W. A., et al. (1992) · American Journal of Clinical Oncology · doi:10.1097/00000421-199204000-00008 · Cited by 13 · see citing works
Synthesis of Antifeedants for Insects: Novel Behaviour‐Modifying Chemicals from Plants
Ley, S. V. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514009.ch7 · Cited by 13 · see citing works
Zamith, H. P. S., Paumgartten, F. J. R., & Speit, G. (1996) · Mutation Research/Genetic Toxicology · doi:10.1016/s0165-1218(96)90035-x · Cited by 11 · see citing works
Phase II trial of indicine N-oxide in relapsed pediatric solid tumors
Miser, J. S., Smithson, W. A., Krivit, W. A., et al. (1991) · Investigational New Drugs · doi:10.1007/bf00183576 · Cited by 11 · see citing works
TunÃn, H., & Bruhn, J. G. (1995) · Nature · doi:10.1038/376546a0 · Cited by 9 · see citing works
Han, R. (1994) · PubMed · Cited by 8 · see citing works
Han, R. (1995) · PubMed · Cited by 6 · see citing works
韩锐 (1994) · 中国医学科学杂志:英文版 · Cited by 5 · see citing works
Molecular Toxicology of Pyrrolizidine Alkaloids
Kim, H.-Y. (2021) · Digital Commons - USU (Utah State University) · doi:10.26076/5986-843b · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 14
- Chabner BA. Anti-cancer drugs. (Chapter 18). In: DeVita VT Jr, Hellman S, Rosenberg AS, eds. Cancer: Principles and Practice, Fourth Edition. Philadelphia: Lippincott, 1991:325-417.
- Jessup JM, McGinnis LS, Winchester DP et al. Clinical highlights from the National Cancer Database: 1996. CA Cancer J Clin 1996;46:185-187.
- 4 Fact sheet. Twelve major cancers. Scientific Am 1996;275:92-98.
- Harvey AL. Advances in Drug Discovery Techniques. Chicester: John Wiley & Sons, 1998.
- Creemers GJ, Bolis G, Gore M et al. Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer. J Clin Oncol 1996;14:3056-3061.
- Kantarjian HM, O'Brien S, Anderlini P et al. Treatment of myelogenous leukemia: current status and investigational options. Blood 1996;87:3069-3081.
- Harmon AD, Weiss U, Silverton JV. The structure of rohutukine, the main alkaloid of Amoora rohituka (syn. Aphanamixis polystachya) (Maliaceae). Tetrahydron 1979;8:721-724.
- Yamashita Y, Fujii N, Nakano H. Identification of novel topoisomerase I inhibitors. Proc Am Assoc Cancer Res 1994;35:707.
- Gopalakrishna R, Chen Z, Yoolee K et al. Chelerythrine and sanguinarine alkaloids induce membrane translocation and irreversible inactivation of protein kinase C by modifying thiol residues. Proc Am Assoc Cancer Res 1994;35:A3666.
- Boyd MR, Shoemaker RH, McLemore TL et al. New drug development. In: Roth JA, Ruckdescel JC, Weisenburger TH, eds. Thoracic Oncology. Philadelphia: Saunders, 1989:711-721.
- Anderson MM, O'Neill MJ, Phillipson JD et al. In vitro cyto- toxicity of a series of quassinoids from Brucea javanica fruits against KB cells. Planta Med 1991;57:62-64.
- Couldwell WT, Gopalakrishna R, Hinton DR et al. Hypericin: a potential antiglioma therapy. Neurosurgery 1994;35:705-710. 116
- Takahashi I, Nakanishi S, Kobayashi E et al. Hypericin and pseudohypericin specifically inhibit protein kinase C: possi- ble relation to their antiretroviral activity. Biochem Biophys Res Commun 1989;165:1207-1212. 118
- Von Poser GL, Schripsema J, Ferraz AC et al. Anti-prolifera- tive effects of substances isolated from South-Brazilian Hypericum species. Proc Am Assoc Cancer Res 2000;41:102. 123
Cited by
Sorted by citations
Marine Natural Products: A Source of Novel Anticancer Drugs
Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., et al. (2019) · Marine Drugs · doi:10.3390/md17090491 · Cited by 555 · see citing works
“Also known as seaweed, multicellular macroalgae contain numerous pharmacologically important bioactive elements to include carotenoids, dietary fiber, protein, essential fatty acids, vitamins (A, B, B12, C, D, E), and minerals such as Ca, P, Na, and K [70–73], in addition to polyphenols [74,75].”
BackgroundMarine organisms as a source of new anticancer agents
Schwartsmann, G., da Rocha, A. B., Berlinck, R. G., & Jimeno, J. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00292-8 · Cited by 261 · see citing works
Self-citationCitrus reticulata Blanco peels as a source of antioxidant and anti-proliferative phenolic compounds
Ferreira, S. S., Silva, A. M., & Nunes, F. M. (2018) · Industrial Crops and Products · doi:10.1016/j.indcrop.2017.10.009 · Cited by 133 · see citing works
Athukorala, Y., Ahn, G. N., Jee, Y.-H., Kim, G.-Y., Kim, S.-H., Ha, J.-H., Kang, J.-S., Lee, K.-W., & Jeon, Y.-J. (2009) · Journal of Applied Phycology · doi:10.1007/s10811-008-9368-7 · Cited by 89 · see citing works
- Authors
- Mans, D. R. A., Rocha, A. B., & Schwartsmann, G.
- Affiliations
- Universidade Luterana do Brasil (BR)
- Corresponding author
- Schwartsmann, Gilberto
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-06-01
- Volume
- 5
- Issue
- 3
- Pages
- 185-198
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2077904082
- Cited by
- 254
- References
- 121
- Citations by year
- 2025: 4 · 2024: 6 · 2023: 5 · 2022: 10 · 2021: 16 · 2020: 12 · 2019: 7 · 2018: 15 · 2017: 15 · 2016: 12 · 2015: 17 · 2014: 12 · 2013: 20 · 2012: 18
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Oncologist (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry Medicinal Plant Applications
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Ethnobotanical and Medicinal Plants Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phytochemical Studies and Bioactivities
- Keywords
- anticancer drug discovery, medicinal plants, antiproliferative activity, bioassay-guided fractionation, natural product isolation, ethnopharmacology, antitumor alkaloids, taxanes, camptothecin, Brazil
- MeSH terms
- Antineoplastic Agents, Phytogenic, Brazil, Conservation of Natural Resources, Drug Screening Assays, Antitumor, Humans, Plants, Medicinal, Ethnopharmacology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review